Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /524703

Sandu Pharmaceuticals Ltd.

524703 (SANDUPHQ)

• BSE: 524703 • Delayed

44.90INR -2.6%

0.4689 USD

As of 6 June 2026, Sandu Pharmaceuticals Ltd. has a market cap of $4.53M USD, ranking #44830 globally and #3933 in India. It ranks #3971 in the Healthcare sector, and #279 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

44830

Country Rank

3933

Sector Rank

3971

Industry Rank

279

Key Stats

Market Cap

$4.53MUSD

433.78M INR

Enterprise Value

$4.19MUSD

401.06M INR

Revenue (TTM)

$7.01MUSD

671.5M INR

EBITDA (TTM)

$280.35KUSD

26.84M INR

Net Income (TTM)

$214.3KUSD

20.52M INR

EBITDA Margin

Profit Margin

3.1%

PE Ratio

21.3

PS Ratio

0.6

PB Ratio

1.0

EV/EBITDA

13.8

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Umesh Sandu open_in_new

Employees

303

Founded

1899

Website

sandu.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.6%	2.2%	35%	35%	3.2%	20%	-15%	-20%	-1.8%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	524703 (SANDUPHQ) Sandu Pharmaceuticals Ltd ISIN: INE751D01014 Shares Out.: Shares Outstanding: 9.661M¹ Shares Float: 4.712M² TV: TradingView: BSE: SANDUPHQ SA: Stock Analysis: BOM: 524703 YF: Yahoo Finance: 524703.BO GF: Google Finance: BOM: 524703 BA: Barron's: 524703 MS: Morningstar: XBOM: 524703	44.90 INR	TV: TradingView: BSE: SANDUPHQ SA: Stock Analysis: BOM: 524703 YF: Yahoo Finance: 524703.BO GF: Google Finance: BOM: 524703 BA: Barron's: 524703 MS: Morningstar: XBOM: 524703

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sandu Pharmaceuticals Ltd.

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasava, stressan, ashwagandharishtam, sandu sitopalasava, makarprash, chyavanprash, and ayush kwath. Sandu Pharmaceuticals Limited was founded in 1899 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)

Name	Market Cap (USD) diff.	PE	Country
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 245K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 243K%	22.7	India
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 186K%	23.1	India
Cohance Lifesciences Ltd. NSE: SUVENPHAR	$1.87B 178.87B INR 41K%	199.0	India
Granules India Ltd. NSE: GRANULES	$1.83B 174.85B INR 40K%	32.1	India
Viyash Scientific Ltd. NSE: SEQUENT	$944.92M 90.48B INR 21K%	92.7	India

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 831K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 652K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 350K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 201K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 194K%	-	France
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 115K%	20.0	China

chevron_leftBack